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Organisms within the Mycobacterium avium complex (MAC) may have differential virulence. We compared
33 subjects with MAC pulmonary disease to 75 subjects with a single positive culture without disease.M. avium
isolates were significantly more likely to be associated with MAC pulmonary disease (odds ratio  5.14, 95%
confidence interval  1.25 to 22.73) than M. intracellulare.
Exposure to aerosols containing organisms in the Mycobac-
terium avium complex (MAC) likely occurs often (11, 12), but
resultant pulmonary disease is uncommon (13, 16). The MAC
group of organisms consists of two relatively common named
species, M. avium and M. intracellulare, and a third group of
organisms that until recently were not denoted by species
names. Whether some species of MAC are more likely to cause
pulmonary disease than others is unknown.
(This article was previously published as an abstract [abstr.
A820] and presented as an oral presentation at the May 2007
American Thoracic Society Meeting, San Francisco, CA.)
We performed a case-control study comparing persons with
MAC pulmonary disease to persons with a single positive re-
spiratory culture but no evidence of disease. Persons who had
a respiratory specimen that grew MAC between 1 January
1993 and 30 June 1999 and available medical records were
considered for inclusion (n  600). Case subjects were consid-
ered for inclusion if they met the 1997 American Thoracic
Society criteria for MAC pulmonary disease (1). The following
criteria were used to exclude both potential cases and controls:
(i) human immunodeficiency virus infection, (ii) cystic fibrosis,
(iii) age under 18 years, (iv) recipient of organ or bone marrow
transplant, (v) pulmonary alveolar proteinosis, and (iv) active
tuberculosis. The control group was randomly selected from
patients with a positive respiratory MAC culture who did not
meet American Thoracic Society criteria and had a low likeli-
hood of having MAC pulmonary disease, including no radio-
graphic evidence of MAC pulmonary disease. All controls had
(i) a single positive culture for a MAC organism from a respi-
ratory site (as described above), (ii) negative acid-fast smears
on the same specimen and all other respiratory specimens
collected, and (iii) at least two mycobacterial cultures obtained
from the respiratory tract. Patients were excluded from the
control group if they had (i) a diagnosis of MAC pulmonary
disease by an infectious disease specialist or a pulmonologist,
(ii) received a specific therapy directed at MAC pulmonary
disease (as defined above under inclusion criteria for cases), or
(iii) granulomatous inflammation in any biopsy specimens
taken from the respiratory tract.
Clinical isolates were identified by the Duke Clinical Micro-
biology Laboratory as MAC based on growth characteristics,
lack of pigmentation, biochemical testing, and confirmation
with the MAC AccuProbe (Gen-Probe, San Diego, CA). Du-
plicated samples comprising 10% of the isolates were analyzed
as a quality control.
The internal transcribed spacer region between the 16S
and 23S rRNA genes was amplified from bacterial lysates
using 30 cycles of PCR with the primers CCL (5-TTGTA
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CACACCGCCCGTC-3) and 23S (5-TCTCGATGCCAA
GGCATCCACC-3) (5). Purified PCR products were se-
quenced directly using the internal primer P5B (5-GACG
AAGTCTAACAAGGTAGC-3) at the Duke University
Medical Center’s DNA Sequencing Facility. Sequences were
aligned by using CLUSTAL W (version 1.83; ftp://ftp.ebi.ac.uk
/pub/software/dos/clustalw/clustalw1.83.XP.zip), and isolates were
assigned to known sequevars based on exact matching. A phylo-
genetic tree was constructed based on maximum likelihood using
PHYLIP 3.65, (http://evolution.gs.washington.edu/phylip.html).
The data were resampled with 100 bootstrap replications. Group-
ings found on more than 70% of the bootstrap replications are
marked on the phylogenetic tree. The relationship between se-
quevar group and case status was assessed by using odds ratios
and exact 95% confidence intervals with SAS version 9.1 (SAS
Systems, Cary, NC).
Forty case subjects were selected, but isolates were only
available for thirty-three. Eighty control subjects were selected,
but four did not have isolates and one had a dual/ambiguous
sequence, leaving seventy-five subjects with analyzable se-
quence data (Table 1). Sequencing of the 16S-23S internal
transcribed spacer from the 108 isolates revealed 22 distinct
sequevars (see the supplemental material), whose phylogenetic
relationships are demonstrated in the Fig. 1. Six isolates
(5.6%) were genetically distant from the rest of the M. avium
complex (“Non-MAC” sequevar group). Sixty-nine (63.9%)
isolates clustered with M. intracellulare, thirteen (12.0%) clus-
tered with M. avium, and twenty (18.5%) clustered with neither
species (“MAC, other”). Compared to M. intracellulare group
isolates, M. avium group isolates were significantly more likely
to be associated with true MAC pulmonary disease (Table 2).
We found a significant association between M. avium seque-
var group MAC isolates and MAC pulmonary disease, with a
5-fold increase in the odds of true MAC pulmonary disease
in the M. avium sequevar group compared to the M. intracel-
lulare sequevar group. However, consistent with other studies
(3, 4, 8, 18, 25), the majority of MAC isolates (63.9%) among
study subjects with or without MAC pulmonary disease be-
longed to the M. intracellulare sequevar group. M. intracellulare
organisms are preferentially aerosolized (compared to M.
avium) (17), resulting in relatively greater potential for respi-
ratory exposure to M. intracellulare. Our data suggest the hy-
pothesis that when respiratory exposure occurs, M. avium may
be more likely to cause pulmonary disease than M. intracellu-
lare; in other words, M. avium might be more virulent after
respiratory exposure, all other factors being equal. M. avium
possesses specific virulence factors not found in M. intracellu-
TABLE 1. Characteristics of case and control subjects
Parameter





Female 30 (91) 29 (39) 0.0001
Mean age (SD) in yr 65.6 (11.1) 60.1 (15.2) 0.039
Race/ethnicity: 0.0001
White 30 (91) 47 (63)
Black 1 (3) 26 (35)
Other/unknown 2 (6) 2 (3)
Diabetic 1 (3) 13 (7) 0.043
Chronic obstructive pulmonary
disease
6 (18) 30 (40) 0.027
Gastroesophageal reflux 5 (15) 10 (13) 0.80
Malignancy 1 (3) 13 (17) 0.060
Fibrotic lung disease 0 (0) 3 (4) 0.55
Collagen vascular disease 4 (12) 8 (11) 1.0
a Values are expressed as indicated except as noted for mean age in column 1.
FIG. 1. Phylogenetic tree of M. avium complex isolates based on
16S-23S internal transcribed spacer sequences. Line segment lengths
represent phylogenetic distances based on maximum-likelihood anal-
ysis. The dots represent groupings found on more than 70% of boot-
strap replications. “Min” isolates are isolates that cluster with M.
intracellulare, “Mav” isolates cluster with M. avium, and “MAC” iso-
lates cluster with neither species. “Nov” isolates represent novel se-
quevars (not previously described). Other mycobacterial species are
included in the tree for reference. Arrows demonstrate the groups
selected for analysis. The box inset in panel A represents organisms
belonging to the Mycobacterium avium complex; this section of the tree
is expanded and represented in panel B. Numbers next to sequevar
names represent the total number of subject isolates (case or control)
that belonged to this sequevar group.







Intracellulare 21 48 1.0 (ref)
Avium 9 4 5.14 (1.42–18.6)
MAC, other 2 18 0.25 (0.05–1.19)
Non-MAC 1 5 0.46 (0.05–4.16)
a OR, odds ratio; CI, confidence interval; ref, reference group.
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lare (3, 19), is better able to invade and replicate inside mac-
rophages than M. intracellulare (14), and has been associated
with more invasive forms of MAC disease (3, 10, 21, 27).
Our data differ from the findings of a recent study by Han et
al., who found that M. avium (identified by 16S rRNA sequenc-
ing) isolated from clinical specimens was actually less likely to
be associated with pulmonary disease than was M. intracellulare
(9). In that study, M. avium isolation was strongly associated
with hematologic malignancy but did not often cause clinical
disease (16.1% of isolates), while 63.1% of patients with M.
intracellulare had clinical disease. Since that study was con-
ducted at a cancer referral hospital, the vast majority of pa-
tients had malignancies, so the results are unlikely to reflect
what occurs in the general population. Furthermore, the study
was cross-sectional, so misclassification of disease status may
have occurred. Geographic strain differences resulting in dif-
ferential exposure and resultant disease may also explain the
difference between the Han et al. study and the present study.
Our data have several inherent limitations. Only one myco-
bacterial isolate per case subject was examined. MAC pulmo-
nary disease is often polyclonal (25), and reinfection with new
strains occurs frequently (24). Examining only one isolate
may have resulted in misclassification of the infecting MAC
sequevar in some case subjects. However, this misclassification
would be most likely nondifferential and therefore would re-
duce the association between any particular sequevar and case
status. Some subjects who truly had MAC pulmonary disease
may have been inappropriately assigned to the control group.
Again, this misclassification would tend to reduce any observed
associations between case status and sequevar group. The de-
mographics and comorbidities of the case and control groups
were quite different, and observed differences in sequevar dis-
tributions may have been a result of confounding. Our study
lacked statistical power to thoroughly explore this question,
but in an exploratory analysis, no demographic/comorbidity
was significantly associated with sequevar group (data not
shown). Patients with fibrocavitary MAC pulmonary disease
were not well represented in our study, and the sequevars
associated with disease among patients with fibrocavitary MAC
may well differ from those associated with disease among pa-
tients with nodular/bronchiectatic MAC.
The 2007 American Thoracic Society/Infectious Diseases
Society of America guidelines for treatment of nontuberculous
mycobacterial infections recommend that all clinically signifi-
cant nontuberculous mycobacteria should be identified to the
species level (7). Our data emphasize the importance of spe-
cies identification in understanding the role of nontuberculous
mycobacteria in lung disease. DNA sequencing of mycobacte-
rial isolates is a powerful and increasingly popular method for
speciation. The use of the 16S-23S internal transcribed spacer
is a well-validated method to divide mycobacteria into species
and subspecies groups (5, 6, 15, 26); other commonly used loci
are the 16S ribosomal (3), rpoB (2), and hsp65 (20) genes. Use
of these techniques has enabled provisional assignment of new
species names to at least two previously unspeciated organisms
within MAC (22, 23). Further studies using these techniques to
study well-defined patient groups will be necessary to better
understand the role of MAC in human disease.
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